180 related articles for article (PubMed ID: 9303970)
1. [Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung].
Sánchez Céspedes M; López Cabrerizo MP; Moreno I; Ariza A; Monzó M; Rosell R
Med Clin (Barc); 1997 May; 109(1):1-5. PubMed ID: 9303970
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
3. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer.
D'Amico D; Carbone DP; Johnson BE; Meltzer SJ; Minna JD
Cancer Res; 1992 Apr; 52(7):1996-9. PubMed ID: 1348017
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation.
Cooper CA; Bubb VJ; Smithson N; Carter RL; Gledhill S; Lamb D; Wyllie AH; Carey FA
J Pathol; 1996 Sep; 180(1):33-7. PubMed ID: 8943812
[TBL] [Abstract][Full Text] [Related]
7. Widespread molecular alterations present in stage I non-small cell lung carcinoma fail to predict tumor recurrence.
Baksh FK; Dacic S; Finkelstein SD; Swalsky PA; Raja S; Sasatomi E; Luketich JD; Fernando HC; Yousem SA
Mod Pathol; 2003 Jan; 16(1):28-34. PubMed ID: 12527710
[TBL] [Abstract][Full Text] [Related]
8. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
9. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.
Sanz-Ortega J; Bryant B; Sanz-Esponera J; Asenjo JA; Saez MC; Torres A; Balibrea JL; Sobel ME; Merino MJ
Pathol Res Pract; 1999; 195(10):677-80. PubMed ID: 10549031
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.
Fong KM; Kida Y; Zimmerman PV; Ikenaga M; Smith PJ
Cancer Res; 1995 Oct; 55(19):4268-72. PubMed ID: 7671234
[TBL] [Abstract][Full Text] [Related]
12. [Detection of loss of heterozygosity by microsatellite probe and DNA content analysis].
Chiba W; Sawai S; Ikeda S; Kinoshita M; Hatama T; Shin S; Fujimoto T; Miyajima S; Wazawa H; Hanawa T
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():158-63. PubMed ID: 7611781
[TBL] [Abstract][Full Text] [Related]
13. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
14. [Studies of microsatellite instability and loss of heterozygosity at chromosome 17 in non-small cell lung carcinoma].
Guo X; Ni P; Li L
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Dec; 22(12):743-5. PubMed ID: 11776784
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
[TBL] [Abstract][Full Text] [Related]
17. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
[TBL] [Abstract][Full Text] [Related]
18. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
19. LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions. Prognostic implications.
Sanz-Ortega J; Sanz-Esponera J; Caldes T; Gomez de la Concha E; Sobel ME; Merino MJ
Pathol Res Pract; 1996 Dec; 192(12):1206-10. PubMed ID: 9182290
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]